May 2018 FDA Recall Piperacillin And Tazobactam by Auromedics Pharma Llc
D-0926-2018 - Presence of Particulate Matter

This Class I drug recall was voluntarily initiated by Auromedics Pharma Llc on May 1, 2018 for the product Piperacillin And Tazobactam. The FDA reported the reason for recall as presence of particulate matter. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0926-2018

Reason for Recall
Presence of Particulate Matter: confirmed customer report for presence of visible particulate matter, confirmed as glass
Initiated
05-01-2018
Reported
05-23-2018
Quantity
77,400 vials

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
AuroMedics Pharma LLC
Nationwide in the USA
Piperacillin and Tazobactam for Injection, USP 3.375 grams per vial, For Intravenous Use Only, Single-Dose vial, Rx Only, Manufactured for: AuroMedics Pharma LLC, 6 Wheeling Road, Dayton, NJ 05610. NDC 55150-120-30

Batch or Lot Expiration Information

Lot# s: PP0317061-A, PP0317049-A; EXP August 2019